Back
Cstone Pharmaceuticals
Founded by : -, 1 January 2016
About the Company
CStone (HKEX: 2616) is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established in 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. The company has built an oncology-focused pipeline of 15 drug candidates with a strategic emphasis on immuno-oncology combination therapies. Currently, CStone has received ten NDA approvals for four drugs. Multiple late-stage drug candidates are now under pivotal clinical trials or registration. CStone's vision is to become globally recognized as a world-renowned biopharmaceutical company by bringing innovative oncology therapies to cancer patients worldwide.
Industry Type
According to the GICS (Global Industry Classification Standard) version of March 2023, Cstone Pharmaceuticals’s industry classification falls within the following categories:
- Sector: -
- Industry group: -
- Industry: -
- Sub-Industry: -
No preview available
Company Address
Shanghai, Shanghai, China
Source : Google maps